Acute Myeloid Leukemia and Midostaurin Care

Acute myeloid leukemia (AML) begins with clonal expansion of immature myeloid precursors. These myeloblasts accumulate in the marrow and blood, leaving less space and capacity for normal red-cell, granulocyte, and platelet production. One disease process can therefore produce fatigue or dyspnea from anemia, infection risk from neutropenia, and bleeding from thrombocytopenia. Treatment adds a second time-sensitive problem. Rapid destruction of leukemic cells can precipitate tumor lysis syndrome, while chemotherapy-related neutropenia can make fever an emergency. For the LVN/LPN, safe care means recognizing abnormal trends, carrying out clear orders, reassessing response, and promptly reporting findings that exceed stable, predictable care or require clinical judgment beyond practical-nurse scope.